Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan vs Losartan in Grade I-II Arterial Hypertension
NCT02248961Phase 3Completed
- Sponsor
- R-Pharm
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fimasartan in hypertension (HTN), sponsored by R-Pharm. Started May 2014; status: completed.
02
Drugs
fimasartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02248961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248961.